cantor fitzgerald
Entity, reached from Hormuz.
- Evidence
- 58 documents · 25 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 3 Sept 2026, last seen 9 Oct 2026
- Measured
- 12% of mentions say something specific about it; the rest only name it
- As of
- 9 Oct 2026
Where this comes from
- MarketBeat News Feed · 2026-10-08 · Cantor Fitzgerald Issues Positive Forecast for Eli Lilly and Company (NYSE:LLY) Stock Price (opens the source in a new tab)
- MarketBeat News Feed · 2026-09-28 · Ascendis Pharma A/S (NASDAQ:ASND) Earns Overweight Rating from Cantor Fitzgerald (opens the source in a new tab)
- MarketBeat News Feed · 2026-09-22 · Cantor Fitzgerald Boosts PTC Therapeutics (NASDAQ:PTCT) Price Target to $137.00 (opens the source in a new tab)
- MarketBeat News Feed · 2026-09-18 · Cantor Fitzgerald Forecasts Strong Price Appreciation for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock (opens the source in a new tab)
What is claimed about it
- Could not check: We could not count this claim's sources, so we do not say how well it is supported.
- U.S. Senator Questions Cantor Fitzgerald Over Tether’s Iran-Linked USDT Activity Could not check · a claim about it
- Senate Democrat Presses Cantor Fitzgerald on Tether Ties and Lutnick Family Profits Could not check · a claim about it
Situations it is named in
Who it moves with
- co-mentioned with buy (34 documents)seen together
- co-mentioned with wall street (30 documents)seen together
- co-mentioned with ai (25 documents)seen together
- co-mentioned with strong buy (21 documents)seen together
- co-mentioned with nasdaq (21 documents)seen together
- co-mentioned with institutional investors (18 documents)seen together
- co-mentioned with sec (16 documents)seen together
- co-mentioned with crypto (14 documents)seen together